Wells Fargo & Company Royalty Pharma PLC Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Royalty Pharma PLC stock. As of the latest transaction made, Wells Fargo & Company holds 48,156 shares of RPRX stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,156
Previous 50,345
4.35%
Holding current value
$1.31 Million
Previous $1.53 Million
16.95%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RPRX
# of Institutions
406Shares Held
290MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.2 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$626 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$439 Million0.35% of portfolio
-
Viking Global Investors LP12MShares$326 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...